These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 26410808)
41. Dual fluorescent HPMA copolymers for passive tumor targeting with pH-sensitive drug release: synthesis and characterization of distribution and tumor accumulation in mice by noninvasive multispectral optical imaging. Hoffmann S; Vystrčilová L; Ulbrich K; Etrych T; Caysa H; Mueller T; Mäder K Biomacromolecules; 2012 Mar; 13(3):652-63. PubMed ID: 22263698 [TBL] [Abstract][Full Text] [Related]
42. Antitumor activity of N-(2-hydroxypropyl) methacrylamide copolymer-Mesochlorine e6 and adriamycin conjugates in combination treatments. Shiah JG; Sun Y; Peterson CM; Straight RC; Kopecek J Clin Cancer Res; 2000 Mar; 6(3):1008-15. PubMed ID: 10741728 [TBL] [Abstract][Full Text] [Related]
43. Targeting tumor angiogenesis: comparison of peptide and polymer-peptide conjugates. Line BR; Mitra A; Nan A; Ghandehari H J Nucl Med; 2005 Sep; 46(9):1552-60. PubMed ID: 16157540 [TBL] [Abstract][Full Text] [Related]
44. Liberation of doxorubicin from HPMA copolymer conjugate is essential for the induction of cell cycle arrest and nuclear fragmentation in ovarian carcinoma cells. Malugin A; Kopecková P; Kopecek J J Control Release; 2007 Dec; 124(1-2):6-10. PubMed ID: 17869367 [TBL] [Abstract][Full Text] [Related]
45. Influence of the structure of drug moieties on the in vitro efficacy of HPMA copolymer-geldanamycin derivative conjugates. Kasuya Y; Lu ZR; Kopecková P; Tabibi SE; Kopecek J Pharm Res; 2002 Feb; 19(2):115-23. PubMed ID: 11883637 [TBL] [Abstract][Full Text] [Related]
49. Polysialic acid-polyethylene glycol conjugate-modified liposomes as a targeted drug delivery system for epirubicin to enhance anticancer efficiency. Zhang T; Zhou S; Hu L; Peng B; Liu Y; Luo X; Liu X; Song Y; Deng Y Drug Deliv Transl Res; 2018 Jun; 8(3):602-616. PubMed ID: 29536348 [TBL] [Abstract][Full Text] [Related]
50. Self-Assembled Hybrids of Fluorescent Carbon Dots and PAMAM Dendrimers for Epirubicin Delivery and Intracellular Imaging. Matai I; Sachdev A; Gopinath P ACS Appl Mater Interfaces; 2015 Jun; 7(21):11423-35. PubMed ID: 25946165 [TBL] [Abstract][Full Text] [Related]
51. Combination chemotherapy and photodynamic therapy of targetable N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin/mesochlorin e(6)-OV-TL 16 antibody immunoconjugates. Shiah JG; Sun Y; Kopecková P; Peterson CM; Straight RC; Kopecek J J Control Release; 2001 Jul; 74(1-3):249-53. PubMed ID: 11489502 [TBL] [Abstract][Full Text] [Related]
52. HPMA copolymer conjugates with reduced anti-CD20 antibody for cell-specific drug targeting. I. Synthesis and in vitro evaluation of binding efficacy and cytostatic activity. Etrych T; Strohalm J; Kovár L; Kabesová M; Ríhová B; Ulbrich K J Control Release; 2009 Nov; 140(1):18-26. PubMed ID: 19632282 [TBL] [Abstract][Full Text] [Related]
53. In vitro synergistic action of geldanamycin- and docetaxel-containing HPMA copolymer-RGDfK conjugates against ovarian cancer. Larson N; Roberts S; Ray A; Buckway B; Cheney DL; Ghandehari H Macromol Biosci; 2014 Dec; 14(12):1735-47. PubMed ID: 25185891 [TBL] [Abstract][Full Text] [Related]
54. HPMA copolymer conjugates of paclitaxel and docetaxel with pH-controlled drug release. Etrych T; Sírová M; Starovoytova L; Ríhová B; Ulbrich K Mol Pharm; 2010 Aug; 7(4):1015-26. PubMed ID: 20518512 [TBL] [Abstract][Full Text] [Related]
55. Conjugates of doxorubicin with graft HPMA copolymers for passive tumor targeting. Etrych T; Chytil P; Mrkvan T; Sírová M; Ríhová B; Ulbrich K J Control Release; 2008 Dec; 132(3):184-92. PubMed ID: 18534705 [TBL] [Abstract][Full Text] [Related]
56. Gamma scintigraphy of the biodistribution of 123I-labelled N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugates in mice with transplanted melanoma and mammary carcinoma. Pimm MV; Perkins AC; Strohalm J; Ulbrich K; Duncan R J Drug Target; 1996; 3(5):375-83. PubMed ID: 8866656 [TBL] [Abstract][Full Text] [Related]
57. P(HPMA)-block-P(LA) copolymers in paclitaxel formulations: polylactide stereochemistry controls micellization, cellular uptake kinetics, intracellular localization and drug efficiency. Barz M; Armiñán A; Canal F; Wolf F; Koynov K; Frey H; Zentel R; Vicent MJ J Control Release; 2012 Oct; 163(1):63-74. PubMed ID: 22613881 [TBL] [Abstract][Full Text] [Related]
58. Synthesis and Properties of Star HPMA Copolymer Nanocarriers Synthesised by RAFT Polymerisation Designed for Selective Anticancer Drug Delivery and Imaging. Chytil P; Koziolová E; Janoušková O; Kostka L; Ulbrich K; Etrych T Macromol Biosci; 2015 Jun; 15(6):839-50. PubMed ID: 25731143 [TBL] [Abstract][Full Text] [Related]
59. Relevance of folic acid/polymer ratio in targeted PEG-epirubicin conjugates. Canal F; Vicent MJ; Pasut G; Schiavon O J Control Release; 2010 Sep; 146(3):388-99. PubMed ID: 20621587 [TBL] [Abstract][Full Text] [Related]